Brief: PainReform Provides Further Update On Phase 3 Clinical Trial Of PRF-110

PRF Technologies

27/12/2024 15:24

Dec 27 (Reuters) - PainReform Ltd  PRFX.O :
    * PAINREFORM PROVIDES FURTHER UPDATE ON PHASE 3 CLINICAL
TRIAL OF
PRF-110
    * PAINREFORM LTD: DATA FROM FINAL 24-HOUR PERIOD COULD NOT
BE
CLARIFIED TO SATISFY STUDY'S PRIMARY ENDPOINT 72 HOURS
REQUIREMENT
    * PAINREFORM LTD: DATA FROM FINAL 24-HOUR PERIOD DID NOT
MEET
PRIMARY ENDPOINT OF STUDY
    * PAINREFORM LTD - INITIATES RESEARCH AND DEVELOPMENT
ACTIVITIES
TO REFINE PHARMACO-KINETICS AND PHARMACO-DYNAMICS OF PRF-110

Source text:  ID:nGNX6zvpVc 
Further company coverage:  PRFX.O 

 ((Reuters.Briefs@thomsonreuters.com;))